Gene therapy with voretigene neparvovec-rzyl partially restores geniculostriate pathway function in LCA2 patients, improving visual processing. Initial LCA2 pathology shifts visual processing from the ...
Neuroscientists have been trying to understand how the brain processes visual information for over a century. The development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback